Technology-based Symptom Monitoring Intervention for Locally Advanced Head and Neck Cancer Patients - Trial NCT06385587
Access comprehensive clinical trial information for NCT06385587 through Pure Global AI's free database. This phase not specified trial is sponsored by Aptar Digital Health and is currently Not yet recruiting. The study focuses on Head and Neck Cancer. Target enrollment is 30 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Aptar Digital Health
Timeline & Enrollment
N/A
May 03, 2024
Sep 27, 2025
Primary Outcome
Users' satisfaction
Summary
The goal of this observational study is to assess the satisfaction and usability of an
 interactive and patient-centered mobile application (app), Oleena™, designed to assist head
 and neck cancer patients undergoing chemoradiation in managing common and distressing
 symptoms in real-time, as well as to assess the satisfaction and usability of the related HCP
 web portal. Additional secondary usage and clinical endpoints that would be used to assess
 intervention efficacy in future trials will be collected.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06385587
Device Trial